This article provides an overview of the clinical and economic issues associated with hypoglycemia in patients with type 1 and type 2 diabetes mellitus. Current research regarding hypoglycemia is comprehensively reviewed, with special emphasis on nocturnal hypoglycemia, as almost 50% of all severe hypoglycemic episodes occur at nighttime during sleep. Current findings on the economic and human burden of hypoglycemia are presented.
Conclusions
Poor diabetes self-management leads to an increased risk for hypoglycemia and the development of long-term complications associated with poor glycemic control. Hypoglycemia is also associated with increased health care costs and resources required to treat hypoglycemic events, as well as personal financial costs and loss of productivity at school or work. In addition, fear, anxiety, and worry about hypoglycemic episodes are shown to interfere with patients’ quality of life. Nocturnal hypoglycemia can cause a number of immediate clinical consequences, including convulsions, coma, and even death. Repeated long-term exposure to nocturnal hypoglycemia can blunt counterregulatory mechanisms that maintain glucose levels, leading to reduced cognitive function, impaired awareness of hypoglycemia, and hypoglycemia-associated autonomic failure. Clinicians must be aware of the impact of hypoglycemia, particularly nocturnal hypoglycemia, so that they can prescribe appropriate glucose-lowering therapy and educate patients about the prevention and management of hypoglycemic events to reduce anxiety and improve quality of life.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
3.
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
4.
American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(suppl 1):S11-S63.
The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991;90:450-459.
7.
LipskaKJWartonEMHuangES. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013;36:3535-3542.
8.
SeaquistERAndersonJChildsB. Hypoglycemia and diabetes: a report of a workgroup of the american diabetes association and the endocrine society. Diabetes Care. 2013;36:1384-1395.
9.
GabrielyIShamoonH. Hypoglycemia in diabetes: common, often unrecognized. Cleve Clin J Med. 2004;71:335-342.
10.
BayCKristensenPLPedersen-BjergaardUTarnowLThorsteinssonB. Nocturnal continuous glucose monitoring: accuracy and reliability of hypoglycemia detection in patients with type 1 diabetes at high risk of severe hypoglycemia. Diabetes Technol Ther. 2013;15:371-377.
LermanIGWolfsdorfJI. Relationship of nocturnal hypoglycemia to daytime glycemia in IDDM. Diabetes Care. 1988;11:636-642.
13.
ChicoAVidal-RiosPSubiraMNovialsA. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care. 2003;26:1153-1157.
14.
MunshiMNSegalARSuhlE. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med. 2011;171:362-364.
15.
SignorovitchJEMacaulayDDienerM. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab. 2012;15:335-341.
16.
TattersallRBGillGV. Unexplained deaths of type 1 diabetic patients. Diabet Med. 1991;8:49-58.
17.
WestonPJGillGV. Is undetected autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus? The “dead in bed” syndrome revisited. Diabet Med. 1999;16:626-631.
18.
TanenbergRJNewtonCADrakeAJ. Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract. 2010;16:244-248.
19.
GillGVWoodwardACassonIFWestonPJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes—the “dead in bed” syndrome revisited. Diabetologia. 2009;52:42-45.
CryerPE. Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab. 2001;281:E1115-E1121.
24.
CryerPE. The barrier of hypoglycemia in diabetes. Diabetes. 2008;57:3169-3176.
25.
BrisoceSADavisSN. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and managment. Clin Diabetes. 2006;24:115-121.
26.
de GalanBESchouwenbergBJTackCJSmitsP. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes. Neth J Med. 2006;64:269-279.
27.
BanarerSCryerPE. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes. 2003;52:1195-1203.
28.
YoungA. Inhibition of glucagon secretion. Adv Pharmacol. 2005;52:151-171.
29.
UngerRHCherringtonAD. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest. 2012;122:4-12.
30.
SegelSAParamoreDSCryerPE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002;51:724-733.
31.
VenemanTMitrakouAMokanMCryerPGerichJ. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes. 1993;42:1233-1237.
32.
BruntonSA. Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs. MedGenMed. 2007;9:38.
33.
CryerPChildsB. Negotiating the barrier of hypoglycemia in diabetes. Diabetes Spectrum. 2002;15:20-27.
34.
CoxDJIrvineAGonder-FrederickLNowacekGButterfieldJ. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10:617-621.
35.
FidlerCElmelundCTGillardS. Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ. 2011;14:646-655.
36.
LawtonJRankinDElliottJ. Experiences, views, and support needs of family members of people with hypoglycemia unawareness: interview study. Diabetes Care. 2014;37:109-115.
37.
WildDvonMRBrohanEChristensenTClausonPGonder-FrederickL. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns. 2007;68:10-15.
38.
PolonskyWHDavisCLJacobsonAMAndersonBJ. Correlates of hypoglycemic fear in type I and type II diabetes mellitus. Health Psychol. 1992;11:199-202.
39.
SheuWHJiLNNitiyanantW. Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region. Diabetes Res Clin Pract. 2012;96:141-148.
40.
LeiterLYaleJChiassonJHarrisSKleinstiverPSauriolL. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Canadian Journal of Diabetes. 2005;29:186-192.
41.
MarrettERadicanLDaviesMJZhangQ. Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: a survey study. BMC Res Notes. 2011;4:251.
42.
KingPKongMFParkinHMacdonaldIATattersallRB. Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care. 1998;21:341-345.
43.
FanelliCGParamoreDSHersheyT. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 1998;47:1920-1927.
44.
DavisREMorrisseyMPetersJRWittrup-JensenKKennedy-MartinTCurrieCJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin. 2005;21:1477-1483.
45.
BohmePBertinECossonEChevalierN. Fear of hypoglycaemia in patients with type 1 diabetes: do patients and diabetologists feel the same way?Diabetes Metab. 2012;39:63-70.
46.
RatnerREGoughSCLMathieuC. Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes Obes Metab. 2013;15:175-184.
47.
KovacsBKNicolucciAHoltRI. Diabetes Attitudes, Wishes and Needs second study (DAWN2): cross-national benchmarking indicators for family members living with people with diabetes. Diabet Med. 2013;30:778-788.
48.
WilliamsSAShiLBrennemanSKJohnsonJCWegnerJCFonsecaV. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. J Diabetes Complications. 2012;26:399-406.
49.
ZhangYWiefferHModhaR. The burden of hypoglycemia in type 2 diabetes: a systematic review of patient and economic perspectives. JCOM. 2010;17:547-557.
50.
HarrisSLeiterLYaleJChiassonJKleinstiverPSouriolL. Out-of-pocket costs of managing hyperglycemia and hypoglycemia in patients with type 1 diabetes and insulin-treated type 2 diabetes. Can J Diabetes. 2007;31:25-33.
51.
BrodMChristensenTBushnellDM. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey. J Med Econ. 2012;15:77-86.
52.
BrodMChristensenTThomsenTLBushnellDM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health. 2011;14:665-671.
53.
BrodMWoldenMChristensenTBushnellDM. A nine country study of the burden of non-severe nocturnal hypoglycemic events on diabetes management and daily function. Diabetes Obes Metab. 2013;25:546-557.
54.
BarnettAHCradockSFisherMHallGHughesEMiddletonA. Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract. 2010;64:1121-1129.
55.
Ismail-BeigiFMoghissiETiktinMHirschIBInzucchiSEGenuthS. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154:554-559.
56.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care. 2010;33:1004-1008.
57.
WoodwardAWestonPCassonIFGillGV. Nocturnal hypoglycaemia in type 1 diabetes—frequency and predictive factors. QJM. 2009;102:603-607.
58.
VallaV. Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps. Exp Diabetes Res. 2010;2010: 178372.
